
Nestle products may complement GLP-1 weight-loss drugs
VEVEY, SWITZERLAND — The increasing use of GLP-1 agonists drugs for type 2 diabetes and weight loss could present opportunities for Nestle SA. “I believe we have important contributions to make,” said Ulf Mark Schneider, chief executive officer, in an…